Old Web
English
Sign In
Acemap
>
Paper
>
Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
Reply: Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis
2019
Y. Allenbach
Loïs Bolko
Ségolène Toquet
Océane Landon-Cardinal
O. Benveniste
Keywords:
Neuroscience
Juvenile dermatomyositis
Baricitinib
Janus kinase 1
Diabetes mellitus
Medicine
Pharmacology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
13
References
1
Citations
NaN
KQI
[]